The Drosophila models used in our study, however, express Aβ42 peptides or tau in the absence of any confounding factors upstream of their production, hyperphosphorylation or accumulation, and so enable a more definitive analysis of the processes occurring directly downstream of these pathologies in AD. The gene discussed is MAPT; the disease is Alzheimer disease.